Veterinary Medicines

Pentoxin, 500mg/ml, Injekční roztok

Authorised
  • Pentobarbital
Download as PDF

Product identification

Medicine name:
Pentoxin, 500mg/ml, Injekční roztok
Active substance:
  • Pentobarbital
Target species:
  • Chicken
  • Pigeon
  • Ornamental bird
  • Dog
  • Cat
  • Mink
  • Polecat
  • Hare
  • Rabbit
  • Guinea pig
  • Hamster
  • Rat
  • Mouse
  • Horse
  • Cattle
  • Horse (pony)
  • Pig
  • Reptile
  • Frog
Route of administration:
  • Intrapulmonary use
  • Intravenous use
  • Intracardiac use
  • Intraperitoneal use

Product details

Active substance and strength:
  • Pentobarbital
    455.70
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intrapulmonary use
    • Chicken
      • Meat and offal
        no withdrawal period
    • Pigeon
      • Meat and offal
        no withdrawal period
  • Intravenous use
    • Hare
      • Meat and offal
        no withdrawal period
    • Rabbit
      • Meat and offal
        no withdrawal period
    • Chicken
      • Meat and offal
        no withdrawal period
    • Pigeon
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
    • Cattle
      • Meat and offal
        no withdrawal period
    • Horse (pony)
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
  • Intracardiac use
    • Hare
      • Meat and offal
        no withdrawal period
    • Rabbit
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
  • Intraperitoneal use
    • Hare
      • Meat and offal
        no withdrawal period
    • Rabbit
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • C&H Generics Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/032/20-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 5/05/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 27/02/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 27/02/2025
Download